RUS
BIOPHARM
BioPharmaceutical Company
Our mission
Our Mission is to improve the quality of life and longevity of Patients.

We are developing and implementing Innovative approaches in BioPharmaceuticals to better serve Patients with life-impacting diseases.

Every Patient in the world has the right to Quality Medical treatment. Our goal is to make it affordable.

Who We Are
Rus BioPharm was founded in 2012, as an Integrated full-cycle BioPharmaceutical Company with a focus on:

  • Biological Products and Biosimilars
  • Full portfolio of Asthma and COPD drugs
  • Innovative and technology driven formulations / complex generics
Rus BioPharm is focused on manufacturing of complex generics and biosimilars for severe diseases, including orphan indications.

Rus BioPharm's R&D efforts are directed towards development of well know molecules as well as combination of drugs previously not available in Russia. These combination drugs would vastly enhance the quality of life of the patients and make the drugs more affordable.

Rus BioPharm is also working on development of innovative drugs and biological drugs, with a focus on auto-immune diseases.
Film about of company
full film version
Whom We Serve
  • Patients in need of high quality and affordable drugs
  • We develop innovations and localize the production of medicines to increase the availability of medicines for patients
100
100 Drug Products in development
11
11 of which are Biosimilars
9
Facility fully equipped to manufacture 9 Drug Forms
Our Team
Rus BioPharm is a team of highly trained professionals with vast experience and key knowledge of the Pharmaceutical Industry
Satya Karm Punia
President of Rus BioPharm Group
Evgenia Shapiro
Director General
Denis Novakovsky
Vice president - business development
Vyacheslav Vodnev
Director of Plant Operations
30+
More than 30 experienced professionals in R&D
350+
More than 250 employees at the manufacturing facility in Special Economic Zone, Dubna City, Moscow Region.
Lead Therapeutic Areas
Rus BioPharm is actively substituting imported Drug Products through development and local manufacturing of highly effective and expensive Drug Products, especially the ones listed in the Essential Drugs List.


Along with the Generic Drugs and Biosimilars, Rus BioPharm is also developing and launching novel Drug Products in the Russian market.
The lead therapeutic areas are as follows:
Pulmonology
Rheumatology
Oncology
Antiretroviral therapy
Neurology
Gastroenterology
Assisted Reproductive Technologies
Anesthesiology and Intensive Care Therapies
Orphan Diseases
Our Products
Biological Products and Biosimilars
Inhalation Drugs
Sterile Injectables
Solid Dosage Forms
Biological Products and Biosimilars
One of the key focus area of Rus BioPharm is development of Biological and Biosimilar Drug Products for severe Rheumatology, Onco-Hematology, Gastroenterology and Reproductive disorders.
6 additional Biosimilars in different stages of development
Inhalation Drugs
Pulmonology is one of the key focus areas for Rus BioPharm and Rus BioPharm is developing a wide range of Inhalation Drugs Products for Asthma and Chronic Obstructive Pulmonary Disease, in all possible Drug Forms: Aerosols, Powders, Solutions and Suspensions for inhalation
Metered Dose Inhalers
And more than 4 innovative products at the development stage
Dry Powder Inhalers
And more than 5 innovative products at the development stage (R&D)
Solutions and Suspensions for Inhalation
More than 7 products are under development
Sterile Injectables
Rus BioPharm is developing a wide range of Drugs Products for Hospital segment, such as new generation Antibiotics, Antimycotics, Proton pump inhibitors and a number of other Drugs from the Essential Drugs List, in 3 Drug forms: lyophilizates, Solutions and Concentrates.
More than 13 products are under development
Solid Dosage Forms
Rus BioPharm's OSD Drug Product range covers diseases such as HIV, Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, etc.
More than 4 products are under development
Manufacturing
Rus BioPharm's manufacturing facility is equipped with the latest and best available technology to effectively manufacture finished Drug Products with high added-value.

1
Robust Fill & Finish lines to cover all Drug Forms
2
Implementation of the latest GxP Practices
3
Highly productive manufacturing process with no compromise on Quality
4
Continuous professional development of highly skilled employees

Pharmaceutical Capabilities
Metered Dose Inhalers
Dry Powder Inhalers
Metered Dose Solutions and suspensions for Inhalation
Lyophilised drugs for injection
Solutions and Concentrates for Injections
Solid Dosage Forms
Biological Drugs and Biosimilars – Injectable Solutions Sterile solution (Vial, PFS, Cartridge), Lyophilised form
Kilo Lab for API synthesis -
Pilot small molecule API synthesis
Bioprocessing unit with USP and DSP -
Biological Drug Substance ( Mammalian, Microbial)
Quality control
All Products are manufactured at a modern facility
The plant is equipped with all the necessary manufacturing and analytical equipment, to carry out most vigorous Quality Control assays.
Rus BioPharm uses New Generation Impactors to analyze Inhalation Drug forms, to determine the exact amount of API that reaches the deep parts of lungs during inhalation. This is a key characteristic to determine the quality of these Drug formulations. Rus BioPharm also uses Sympatec to analyze the distribution of particle sizes, to efficiently analyze the quality of the API used
Microbiological and Analytical laboratories have the necessary equipment for the analysis of Biological Products with latest technology and methods.
News
PSK PHARMA will produce API for biotechnology products

Biological synthesis is the most complex process in the pharmaceutical industry, and PSK Pharma is one of the few companies in Russia that successfully develops this area
Analog of the drug for patients with cystic fibrosis will be produced in the Moscow region
The supplier of the first generic sodium colistimethate in Russia can become a resident of the SEZ Dubna - the company " PSK Pharma»
Moscow Region presents its investment potential in New Delhi

Satya Karm Punia, President of Rus BioPharm Group, attended Moscow Region roadshow in New Delhi and shared his experience with fellow Indian investors
PSK Pharma is doubling its investment in the project on the territory of the Dubna SEZ

Biopharmaceutical company PSK Pharma is doubling its investment in the project in Moscow region. We are focused on Asthma and COPD drugs, Innovative and technology driven formulations
The Governor of Moscow Region speaking about Rus BioPharm's facility in SEZ Dubna
The Governor of the Moscow Region, Andrei Vorobyev's interview to TV channel 3600 about the inauguration of Rus BioPharm's Pharmaceutical Manufacturing plant in Special Economic Zone Dubna.
SEZ Dubna resident will help Russians fight rare diseases


PSK Pharma, a resident of the Special Economic Zone Dubna, built a plant to manufacture Innovative Drugs.
Launch of new manufacturing lines of SEZ Dubna residents


Russian Presidential Envoy and the Governor of Moscow Region inaugurated a bridge across Volga and new Manufacturing lines of SEZ Dubna Resident
Cooperation agreement with the Moscow region


Innovative pharmaceutical facility will be established in Dubna city, Moscow region. Investments will amount to about 2.3 billion rubles..
Vacancy
Our multinational team brings together professionals in various areas of the pharmaceutical industry. Along with good growth opportunities, we provide world class working atmosphere to our team members
If you want to be a part of Rus BioPharm team, we are waiting for your resumes at hr@rusbiopharm.ru
    Current Jobs
    Contacts
    Headquarters
    15, 1st Krasnogvardeysky lane,
    39th floor, Mercury Tower,
    Moscow International Business Center,
    123112, Russian Federation,
    Phone: +7 499 400 16 99
    E-mail: office@rusbiopharm.ru

    Manufacturing Facility
    5, Programmistov Street, bld.1
    Special Economic Zone "Dubna"
    Dubna, Moscow Region
    Russian Federation, 141983
    Phone: +7 496 218 19 19
    E-mail: office1@rusbiopharm.ru

    WARNING
    Website content is intended for medical professionals only.
    Please confirm whether you are a medical professional.
    If you are not a medical professional, please leave this website section.